The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival

European Journal of Public Health

Volumn 21, Issue 5, 2011, Pages 573-577

  Asadzadeh Vostakolaei, Fatemeh ^a   Karim Kos, Henrike E ^b   Janssen Heijnen, Maryska L G ^c   Visser, Otto ^d   Verbeek, André L M ^a   Kiemeney, Lambertus A L M ^a,e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c The Netherlands   (Netherlands)

^d Integraal Kankercentrum Amsterdam   (Netherlands)

^e Integraal Kankercentrum Oost   (Netherlands)

Author keywords

cancer; incidence; mortality; prediction; survival

Indexed keywords

ARTICLE; CAUSE OF DEATH; EUROPE; FACTUAL DATABASE; HEALTH SERVICES RESEARCH; HUMAN; INCIDENCE; MORTALITY; NEOPLASM; REGISTER; REGRESSION ANALYSIS; REPRODUCIBILITY; SURVIVAL RATE; UNITED STATES; VALIDATION STUDY;

CAUSE OF DEATH; DATABASES, FACTUAL; EUROPE; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; NEOPLASMS; REGISTRIES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE; UNITED STATES;

EID: 80053554595     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckq120     Document Type: Article

References (14)

1. Kanavos P. The rising burden of cancer in the developing world. Ann Oncol 2006;17(Suppl 8):viii15-viii23. (Pubitemid 43985163)
2. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer 2009;45:756-64.
3. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993;55:891-903. (Pubitemid 24005331)
4. National Cancer Institute. Surveillance Epidemiology and End Results (SEER) http://seer.cancer.gov./factstats.php (April 2007, date last accessed).
5. Netherlands Cancer Registry (NCR). http://www.ikcnet.nl (April 2007, date last accessed).
6. The Association of the NORDIC Cancer Registries (ACNR). http://www-dpo.iarc.fr/nordcan.htm (April 2007, date last accessed).
7. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91.
8. Hebert JR, Daguise VG, Hurley DM, et al. Mapping cancer mortality-to-incidence ratios to illustrate racial and sex disparities in a high-risk population. Cancer 2009;115:2539-52.
9. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al. Prognosis for long-term survivors of cancer. Ann Oncol 2007;18:1408-13. (Pubitemid 47305016)
10. Bore B, Rise L, Ballegooijen M. Ambiguities in calculating cancer patient survival: the SEER experience for colorectal and prostate cancer, Technical Report 2003-05: Statistical Research and Applications Branch, National Cancer Institute; 2005. Report No. 19.
11. Louwman WJ, Klokman WJ, Coebergh JW. Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normal. Br J Cancer 2001;84:700-3. (Pubitemid 32239007)
12. Brenner H, Hakulinen T. Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration. Br J Cancer 2005;92:576-9. (Pubitemid 40395541)
13. Parkin DM, Hakulinen T. Cancer registration: principles and methods: Analysis of survival. IARC Scientific Publication, Lyon, 1991. Report No. 95.
14. Robinson D, Sankila R, Hakulinen T, Møller H. Interpreting international comparison of cancer survival: The effect of incomplete registration and presence of DCO cases on survival estimates. EJC 2007;43:909-13. (Pubitemid 46389484)